Cargando…
Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion
Given the COVID-19 pandemic, there is interest in understanding ligand-receptor features and targeted antibody-binding attributes against emerging SARS-CoV-2 variants. Here, we developed a large-scale structure-based pipeline for analysis of protein-protein interactions regulating SARS-CoV-2 immune...
Autores principales: | Lubin, Joseph H., Markosian, Christopher, Balamurugan, D., Ma, Minh T., Chen, Chih-Hsiung, Liu, Dongfang, Pasqualini, Renata, Arap, Wadih, Burley, Stephen K., Khare, Sagar D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371346/ https://www.ncbi.nlm.nih.gov/pubmed/37261904 http://dx.doi.org/10.1172/jci.insight.168296 |
Ejemplares similares
-
Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces
por: Lubin, Joseph H., et al.
Publicado: (2021) -
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection
por: Markosian, Christopher, et al.
Publicado: (2022) -
Vascular Targeting: Recent Advances and Therapeutic Perspectives
por: Hajitou, Amin, et al.
Publicado: (2006) -
Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003) -
Brain endothelial cell‐targeted gene therapy of neurovascular disorders
por: Marchiò, Serena, et al.
Publicado: (2016)